Credit Suisse plans knock-out notes linked to Bristol-Myers Squibb

By Devika Patel

Knoxville, Tenn., Feb. 1 – Credit Suisse AG, London Branch, plans to price 0% knock-out notes due Feb. 21, 2018 linked to the common stock of Bristol-Myers Squibb Co., according to a 424B2 filing with the Securities and Exchange Commission.

A knock-out event will occur if the final share price is less than the knock-out level, which is expected to be 80% of the initial share price and will be set at pricing.

If a knock-out event has not occurred, the payout at maturity will be par plus the fixed payment percentage, which is expected to be 12.8% and will be set at pricing. If knock-out event has occurred, investors will lose 1% for each 1% decline.

J.P. Morgan Securities LLC is the agent.

The notes (Cusip: 22548QUJ2) are expected to price Feb. 3 and settle Feb. 8.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.